The strategy to filter out virions from infected plasma has been tested with the Middle East respiratory syndrome coronavirus. Why not consider it for SARS-CoV2, asks nephrologist Tejas Desai.

LEAVE A REPLY

Please enter your comment!
Please enter your name here